Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alaris Equity Partners is a Calgary-based publicly traded investment firm that provides long-term preferred equity and minority common equity capital to profitable private companies, primarily in North America. The business was historically known as Alaris Royalty and now operates through Alaris Equity Partners Income Trust and related corporate entities. Rather than developing therapeutics or healthcare products, Alaris structures financing partnerships with middle-market businesses and receives contractual cash distributions that are typically adjusted annually based on top-line performance metrics. Its portfolio spans several industries, including healthcare services, business services, industrial services, and consumer-facing businesses. For a biotech or healthcare analyst, Alaris is best understood as a financial sponsor and investor in healthcare-related services businesses rather than a life science operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alaris Equity Partners.